This prestigious certification affirms Cytomos’ commitment to the highest standards of quality management, risk-based thinking, and customer satisfaction across all operations, from R&D and product development to supply chain and support functions.
“This achievement reflects the exceptional dedication and professionalism of our entire team,” said David Rigterink, CEO of Cytomos. “Achieving ISO 9001 certification without a single non-conformance is a strong endorsement of the robust processes we’ve built to deliver innovation with integrity.”
ISO 9001:2015 is the world’s most recognised quality management system (QMS) standard. It provides a framework for organizations to ensure consistent quality in products and services while continuously improving internal processes.
Cytomos’ successful certification reinforces its position as a trusted partner in the life sciences sector, especially as it prepares for broader commercialisation of its platform technology. The audit covered all aspects of the company’s quality management system, with auditors commending Cytomos for its strong leadership, effective risk controls, and culture of continuous improvement.
“Our customers, partners and investors can be confident that Cytomos operates to the highest international standards,” added Rigterink. “This is not just a badge – it’s a reflection of our mission to deliver reliable, reproducible, and meaningful results in cell analysis.”
To download a copy of our ISO Certificate click here.
12 August 2025
[gravityform id="1" title="false"]